Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16254847rdf:typepubmed:Citationlld:pubmed
pubmed-article:16254847lifeskim:mentionsumls-concept:C0027708lld:lifeskim
pubmed-article:16254847lifeskim:mentionsumls-concept:C0348026lld:lifeskim
pubmed-article:16254847lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:16254847lifeskim:mentionsumls-concept:C1517324lld:lifeskim
pubmed-article:16254847lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:16254847lifeskim:mentionsumls-concept:C2728259lld:lifeskim
pubmed-article:16254847pubmed:issue5lld:pubmed
pubmed-article:16254847pubmed:dateCreated2005-10-28lld:pubmed
pubmed-article:16254847pubmed:abstractTextIn Europe, 1.7 % of children with predicted nephroblastoma undergo neoadjuvant chemotherapy without being correctly diagnosed. It is necessary to reduce the number of misdiagnoses. In a girl who was referred to our institute with the diagnosis of nephroblastoma of the right kidney, DMSA scan revealed a hypertrophic compensation of the contralateral nephropathy in the lower part. Functional imaging studies of the kidney should be performed in patients in whom the type of pathology of a suspect mass in the kidney region is unclear, including a careful scrutiny of the MRI scan.lld:pubmed
pubmed-article:16254847pubmed:languageenglld:pubmed
pubmed-article:16254847pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16254847pubmed:citationSubsetIMlld:pubmed
pubmed-article:16254847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16254847pubmed:statusMEDLINElld:pubmed
pubmed-article:16254847pubmed:monthOctlld:pubmed
pubmed-article:16254847pubmed:issn0939-7248lld:pubmed
pubmed-article:16254847pubmed:authorpubmed-author:SchusterTTlld:pubmed
pubmed-article:16254847pubmed:authorpubmed-author:TillHHlld:pubmed
pubmed-article:16254847pubmed:authorpubmed-author:LehnerMMlld:pubmed
pubmed-article:16254847pubmed:authorpubmed-author:StehrMMlld:pubmed
pubmed-article:16254847pubmed:authorpubmed-author:DietzH-GHGlld:pubmed
pubmed-article:16254847pubmed:issnTypePrintlld:pubmed
pubmed-article:16254847pubmed:volume15lld:pubmed
pubmed-article:16254847pubmed:ownerNLMlld:pubmed
pubmed-article:16254847pubmed:authorsCompleteYlld:pubmed
pubmed-article:16254847pubmed:pagination343-6lld:pubmed
pubmed-article:16254847pubmed:meshHeadingpubmed-meshheading:16254847...lld:pubmed
pubmed-article:16254847pubmed:meshHeadingpubmed-meshheading:16254847...lld:pubmed
pubmed-article:16254847pubmed:meshHeadingpubmed-meshheading:16254847...lld:pubmed
pubmed-article:16254847pubmed:meshHeadingpubmed-meshheading:16254847...lld:pubmed
pubmed-article:16254847pubmed:meshHeadingpubmed-meshheading:16254847...lld:pubmed
pubmed-article:16254847pubmed:meshHeadingpubmed-meshheading:16254847...lld:pubmed
pubmed-article:16254847pubmed:meshHeadingpubmed-meshheading:16254847...lld:pubmed
pubmed-article:16254847pubmed:meshHeadingpubmed-meshheading:16254847...lld:pubmed
pubmed-article:16254847pubmed:meshHeadingpubmed-meshheading:16254847...lld:pubmed
pubmed-article:16254847pubmed:meshHeadingpubmed-meshheading:16254847...lld:pubmed
pubmed-article:16254847pubmed:meshHeadingpubmed-meshheading:16254847...lld:pubmed
pubmed-article:16254847pubmed:year2005lld:pubmed
pubmed-article:16254847pubmed:articleTitleFunctional imaging for determination of nephroblastoma: an obligatory diagnostic program.lld:pubmed
pubmed-article:16254847pubmed:affiliationDepartment of Paediatric Surgery, Dr. von Haunersches Kinderspital, University of München (LMU), Lindwurmstrasse 4, 80337 Munich, Germany. Markus.Lehner@med.uni-muenchen.delld:pubmed
pubmed-article:16254847pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16254847pubmed:publicationTypeCase Reportslld:pubmed